Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...

Antonio CCP, Alida GG, Elena GG, Rocio GS, Jeronimo MG, Luis ARJ, Anibal ND, Francisco BV, Jesus GRA, Pablo RR, Jose GM. Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial. Ann Surg Oncol. 2022 Apr;29(4):2617-2625. doi: 10.1245/s10434-021-11087-7. Epub 2021 Nov 23. PubMed PMID: 34812982.

AÑO: 2022; IF: 3.7

34812982

Aguado de la Rosa C, Cruz Castellanos P, Lazaro-Quintela M, Domine M, Vazquez Estevez S, Lopez-Vivanco G, Firvida Perez JL, Alonso Romero JL, Ferrera Delgado L, Garcia Giron C, Diz Tain P, Alvarez Alvarez R, Mut Sanchis P, Fernandez Canton I, Manrique Abos I, Martinez Aguillo M, Gomez-Aldaravi Gutierrez L, Ortega Granados AL, Alvarez Cabellos R, Garcia Sebastian A, Garcia Sifuentes LF, Reguart N. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study). Lung Cancer. 2022 Nov;173:83-93. doi: 10.1016/j.lungcan.2022.09.010. Epub 2022 Sep 19. PubMed PMID: 36162227.

AÑO: 2022; IF: 5.3

36162227

Mata-Molanes JJ, Rebollo-Liceaga J, Martinez-Navarro EM, Manzano RG, Brugarolas A, Juan M, Sureda M. Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies. Front Oncol. 2022 Jun 24;12:926289. doi: 10.3389/fonc.2022.926289. eCollection 2022. PubMed PMID: 35814459; PubMed Central PMCID: PMC9263556.

AÑO: 2022; IF: 4.7

35814459

de la Cruz-Merino L, Gion M, Cruz J, Alonso-Romero JL, Quiroga V, Moreno F, Andres R, Santisteban M, Ramos M, Holgado E, Cortes J, Lopez-Miranda E, Cortes A, Henao F, Palazon-Carrion N, Rodriguez LM, Ceballos I, Soto A, Puertes A, Casas M, Benito S, Chiesa M, Bezares S, Caballero R, Jimenez-Cortegana C, Sanchez-Margalet V, Rojo F. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study. BMC Cancer. 2022 Dec 3;22(1):1258. doi: 10.1186/s12885-022-10363-3. PubMed PMID: 36463104; PubMed Central PMCID: PMC9719636.

AÑO: 2022

36463104

Ochenduszko, Sebastian; Garcia, Javier; Juan-Fita, Maria Jose; Gonzalez-Barrallo, Ines; Colomina, Julio Herrero; Beveridge, Robert Diaz; Martinez, Silverio Ros; Lafuente, Blanca Sanchez; Tomas, Alberto Jacobo Cunquero; Berrocal, Alfonso; Cerezuela-Fuentes, Pablo; Fra, Pablo Luna; Peeters, Alicia Gervas; Gonzalez, Jose Luis Sanchez; Garcia, Andres Meana; Garcia, Mariasun Algarra; Garcia, Eugenio Palomares; Altozano, Javier Perez; Guerola, Monica Tallon; Maestu, Inmaculada. Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation.. JOURNAL OF CLINICAL ONCOLOGY. 2022; 40(16).

AÑO: 2022; IF: 45.3

< Anterior Siguiente >

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Instituto de Investigación Sanitaria Acreditado

ONCOLOGÍA CLÍNICA Y TRASLACIONAL